查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1600561

CBD 消费者健康市场：按产品、通路 - 2025-2030 年全球预测

CBD Consumer Health Market by Product (Medical OTC Products, Nutraceuticals), Distribution Channel (Online, Retail Pharmacies, Retail Stores) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

CBD消费健康市场2023年估值为107.7亿美元，预计2024年将达到124.6亿美元，复合年增长率为15.79%，到2030年将达到300.7亿美元。

CBD消费者健康市场被定义为将大麻二酚（CBD）融入健康相关产品的领域，旨在促进消费者健康，涵盖范围广泛。消费者对天然和有机健康替代品的认识推动了这一市场需求，并得到越来越多支持 CBD 治疗功效（如缓解疼痛、抗焦虑作用和发炎特性）的研究的支持。应用涵盖多种产品类型，包括营养食品、个人保健产品和药品，最终用户包括注重健康的消费者、运动员和寻求替代疗法的患者。主要成长要素包括合法化趋势、消费者接受度的提高以及电子商务和零售领域分销管道的加强。最新的商业机会来自于在未开发领域开发创新的 CBD 注入解决方案，例如助眠食品、宠物保健食品和心理健康补充品。公司可以透过投资产品多元化、分销策略伙伴关係以及消费者教育计划来增强信誉和信任。然而，局限性仍然存在，包括监管不确定性，特别是 FDA 对 CBD 作为食品添加剂和膳食食品的立场。市场成长挑战包括确保产品品质和一致性以及不同地区之间法律法规的复杂性。创新和研究的最佳领域包括探索 CBD 和其他植物抽取物之间的协同效应，推进奈米封装技术以提高生物利用度，以及验证健康声明，其中包括进行严格的临床试验。关注透明度和教育有助于消除消费者的怀疑。市场本质上是动态且不断发展的，其特点是随着公司寻求有效的差异化，技术创新迅速，竞争力不断增强。透过领先新兴趋势并响应监管开拓，公司可以利用不断扩大的 CBD 健康市场并实现可持续的业务成长。

主要市场统计
基准年[2023] 107.7亿美元
预测年份 [2024] 124.6亿美元
预测年份 [2030] 300.7亿美元
复合年增长率（%） 15.79%

市场动态：揭示快速发展的 CBD 消费者健康市场的关键市场洞察

CBD 消费者健康市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 各国药用大麻合法化
    • 对 CBD食品补充剂的需求增加
    • 健康意识不断提高，越来越多的零售商销售基于 CBD 的产品
  • 市场限制因素
    • 缺乏剂量资讯以及与其他处方笺的负面交互作用
  • 市场机会
    • 医疗保健领域 CBD 相关研究活动的承诺和投资
    • 药用 CBD 进出口增加和 CBD 外用製剂的使用扩大
  • 市场挑战
    • 替代品的可用性、CBD 产品的高价格以及监管问题

波特的五力：驾驭 CBD 消费者健康市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解 CBD 消费保健市场的外部影响

外部宏观环境因素在塑造 CBD 消费者健康市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解 CBD 消费者健康市场的竞争格局

对 CBD 消费者健康市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 在 CBD 消费性健康市场的定位矩阵供应商绩效评估

FPNV 定位矩阵是评估 CBD 消费者健康市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 各国医用大麻合法化
      • 对 CBD 营养食品的需求增加
      • 健康意识不断提高，销售基于 CBD 的产品的零售商数量不断增加
    • 抑制因素
      • 缺乏剂量资讯以及与其他处方药物的不良交互作用
    • 机会
      • 医疗保健领域 CBD 研究工作的承诺和投资
      • 医用 CBD 进出口增加以及 CBD 外用製剂的使用扩大
    • 任务
      • 替代品的可用性、CBD 产品的高价格以及监管问题
  • 市场区隔分析
    • 产品：含有 CBD 的医疗非处方药产品因其可用性和人们对其健康益处的认识而广受欢迎。
    • 通路：消费者线上平台购买 CBD 消费保健品的偏好增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境
  • 客户客製化

第 6 章 CBD 消费者健康市场：副产品

  • 医疗非处方药产品
    • CBD止痛药
    • CBD皮肤科产品
    • CBD心理健康产品
    • CBD助眠产品
  • 食品补充品
    • CBD运动营养
    • CBD 维生素和营养食品
    • CBD体重管理和健康

第七章 CBD 消费保健市场：依通路分类

  • 在线的
  • 零售药房
  • 零售店

第八章美洲 CBD 消费保健市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太CBD消费保健市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲的CBD消费保健市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Irwin Naturals 大麻产品在加拿大推出
    • 座舱罩 Growth 加速进入美国大麻市场
    • 玛莎·史都华 CBD 推出首个品类扩展，推出新的 CBD 健康主题系列

公司名单

  • Endoca BV
  • CBD American Shaman
  • Isodiol International Inc.
  • HEXO Corp.
  • CBDepot sro
  • Curaleaf, Inc.
  • Canopy Growth Corporation
  • Charlotte's Web Holdings, Inc.
  • Columbia Care Inc.
  • Medterra CBD, LLC.
  • Noramco, Inc.
  • Elixinol LLC
  • Jazz Pharmaceuticals, Inc.
  • Aurora Cannabis Inc.
  • Gaia Botanicals, LLC
  • Medical Marijuana, Inc.
  • Kazmira LLC
  • CV Sciences, Inc.
  • Koninklijke DSM NV
  • Global Cannabinoids Inc.
  • CURE Pharmaceutical Holding Corp.
  • Joy Organics LLC
  • NuLeaf Naturals, LLC
  • Croda International PLC
Product Code: MRR-A339DAEFA242

The CBD Consumer Health Market was valued at USD 10.77 billion in 2023, expected to reach USD 12.46 billion in 2024, and is projected to grow at a CAGR of 15.79%, to USD 30.07 billion by 2030.

The CBD consumer health market encompasses a broad scope, defining itself as a sector that integrates cannabidiol (CBD) into health-related products aimed at improving consumer well-being. This market's necessity is driven by increasing consumer awareness regarding natural and organic health alternatives, backed by growing research supporting CBD's therapeutic benefits, such as pain relief, anti-anxiety effects, and anti-inflammatory properties. Applications span various product categories including dietary supplements, personal care products, and pharmaceuticals, with end-users comprising wellness-oriented consumers, athletes, and patients seeking alternative relief options. Key growth influencers include ongoing legalization trends, rising consumer acceptance, and enhanced distribution channels across e-commerce and retail sectors. Latest opportunities arise from developing innovative CBD-infused solutions in underdeveloped areas such as sleep aids, pet wellness, and mental health supplements. Companies can capitalize by investing in product diversification, strategic partnerships for distribution, and consumer education initiatives to bolster credibility and trust. However, limitations remain, including regulatory uncertainties, particularly within the FDA's stance on CBD as a food additive and dietary supplement. Market growth challenges involve the complexity of ensuring product quality and consistency, along with navigating legal restrictions across different regions. Best areas for innovation and research include exploring the synergy of CBD with other botanical extracts, advancing nanoencapsulation techniques to enhance bioavailability, and conducting rigorous clinical trials to substantiate health claims. Emphasizing transparency and education can further help mitigate consumer skepticism. The market is marked by its dynamic and evolving nature, characterized by rapid innovation and competitive advancements as businesses strive to differentiate effectively. By staying ahead of emerging trends and adapting to regulatory developments, companies can leverage the expanding CBD health market for sustained business growth.

KEY MARKET STATISTICS
Base Year [2023] USD 10.77 billion
Estimated Year [2024] USD 12.46 billion
Forecast Year [2030] USD 30.07 billion
CAGR (%) 15.79%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving CBD Consumer Health Market

The CBD Consumer Health Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Legalization of Cannabis for Medicinal Purpose Across Various Countries
    • Increasing Demand for CBD Nutraceuticals
    • Rising Health Awareness and Increase in the Number of Retailers Selling CBD-Based Products
  • Market Restraints
    • Lack of Dose Determination Information and Negative Interaction With Other Prescriptions
  • Market Opportunities
    • Initiatives and Investment taken for Research Activity on CBD in Healthcare
    • Rising Import/Export of Medicinal CBD and Expanding its Usage of CBD Topicals
  • Market Challenges
    • Availability of Alternatives, the High Price of CBD Products, and the Regulatory Concerns

Porter's Five Forces: A Strategic Tool for Navigating the CBD Consumer Health Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the CBD Consumer Health Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the CBD Consumer Health Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the CBD Consumer Health Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the CBD Consumer Health Market

A detailed market share analysis in the CBD Consumer Health Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the CBD Consumer Health Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the CBD Consumer Health Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the CBD Consumer Health Market, highlighting leading vendors and their innovative profiles. These include Endoca BV, CBD American Shaman, Isodiol International Inc., HEXO Corp., CBDepot s.r.o, Curaleaf, Inc., Canopy Growth Corporation, Charlotte's Web Holdings, Inc., Columbia Care Inc., Medterra CBD, LLC., Noramco, Inc., Elixinol LLC, Jazz Pharmaceuticals, Inc., Aurora Cannabis Inc., Gaia Botanicals, LLC, Medical Marijuana, Inc., Kazmira LLC, CV Sciences, Inc., Koninklijke DSM N.V., Global Cannabinoids Inc., CURE Pharmaceutical Holding Corp., Joy Organics LLC, NuLeaf Naturals, LLC, and Croda International PLC.

Market Segmentation & Coverage

This research report categorizes the CBD Consumer Health Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Medical OTC Products and Nutraceuticals. The Medical OTC Products is further studied across CBD Analgesic Products, CBD Dermatology Products, CBD Mental Health Products, and CBD Sleeping Aids Products. The Nutraceuticals is further studied across CBD Sports Nutrition, CBD Vitamins & Dietary Supplements, and CBD Weight Management & Wellbeing.
  • Based on Distribution Channel, market is studied across Online, Retail Pharmacies, and Retail Stores.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Legalization of Cannabis for Medicinal Purpose Across Various Countries
      • 5.1.1.2. Increasing Demand for CBD Nutraceuticals
      • 5.1.1.3. Rising Health Awareness and Increase in the Number of Retailers Selling CBD-Based Products
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of Dose Determination Information and Negative Interaction With Other Prescriptions
    • 5.1.3. Opportunities
      • 5.1.3.1. Initiatives and Investment taken for Research Activity on CBD in Healthcare
      • 5.1.3.2. Rising Import/Export of Medicinal CBD and Expanding its Usage of CBD Topicals
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of Alternatives, the High Price of CBD Products, and the Regulatory Concerns
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Popularity of CBD-infused medical OTC products due to easy availability and improved awareness regarding their health benefits
    • 5.2.2. Distribution Channel: Improved consumer preference for buying CBD consumer health products on online platforms
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. CBD Consumer Health Market, by Product

  • 6.1. Introduction
  • 6.2. Medical OTC Products
    • 6.2.1. CBD Analgesic Products
    • 6.2.2. CBD Dermatology Products
    • 6.2.3. CBD Mental Health Products
    • 6.2.4. CBD Sleeping Aids Products
  • 6.3. Nutraceuticals
    • 6.3.1. CBD Sports Nutrition
    • 6.3.2. CBD Vitamins & Dietary Supplements
    • 6.3.3. CBD Weight Management & Wellbeing

7. CBD Consumer Health Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Online
  • 7.3. Retail Pharmacies
  • 7.4. Retail Stores

8. Americas CBD Consumer Health Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific CBD Consumer Health Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa CBD Consumer Health Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Irwin Naturals Cannabis Products Launch Nationwide in Canada
    • 11.3.2. Canopy Growth to Fast-Track Entry into the U.S. Cannabis Market
    • 11.3.3. Martha Stewart CBD Launches its First-Ever Category Expansion with New Line of CBD Wellness Topicals

Companies Mentioned

  • 1. Endoca BV
  • 2. CBD American Shaman
  • 3. Isodiol International Inc.
  • 4. HEXO Corp.
  • 5. CBDepot s.r.o
  • 6. Curaleaf, Inc.
  • 7. Canopy Growth Corporation
  • 8. Charlotte's Web Holdings, Inc.
  • 9. Columbia Care Inc.
  • 10. Medterra CBD, LLC.
  • 11. Noramco, Inc.
  • 12. Elixinol LLC
  • 13. Jazz Pharmaceuticals, Inc.
  • 14. Aurora Cannabis Inc.
  • 15. Gaia Botanicals, LLC
  • 16. Medical Marijuana, Inc.
  • 17. Kazmira LLC
  • 18. CV Sciences, Inc.
  • 19. Koninklijke DSM N.V.
  • 20. Global Cannabinoids Inc.
  • 21. CURE Pharmaceutical Holding Corp.
  • 22. Joy Organics LLC
  • 23. NuLeaf Naturals, LLC
  • 24. Croda International PLC

LIST OF FIGURES

  • FIGURE 1. CBD CONSUMER HEALTH MARKET RESEARCH PROCESS
  • FIGURE 2. CBD CONSUMER HEALTH MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. CBD CONSUMER HEALTH MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. CBD CONSUMER HEALTH MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CBD CONSUMER HEALTH MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CBD CONSUMER HEALTH MARKET DYNAMICS
  • TABLE 7. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY CBD ANALGESIC PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY CBD DERMATOLOGY PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY CBD MENTAL HEALTH PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY CBD SLEEPING AIDS PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY CBD SPORTS NUTRITION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY CBD VITAMINS & DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY CBD WEIGHT MANAGEMENT & WELLBEING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY RETAIL STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 191. CBD CONSUMER HEALTH MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. CBD CONSUMER HEALTH MARKET, FPNV POSITIONING MATRIX, 2023